1 min read

Why Integrated Registries are Critical for Rare Disease

Learn more in this article from UBC’s Evidence Development team in International Clinical Trials Magazine.
Learn more in this article from UBC's Evidence Development team in International Clinical Trials Magazine.

UBC recently published an article in International Clinical Trials Magazine on how integrated registries can enhance our understanding and ability to treat rare diseases effectively. UBC’s contributing experts included Annette Stemhagen, Senior Vice President and Chief Scientific Officer; Aaron Berger, Vice President of Real World Evidence; and Irene Cosmatos, Senior Real World Data Epidemiologist.

This article discusses:

  • Why integrating registries is necessary in the rare disease space
  • The key data skills involved in building an integrated registry
  • The technical requirements for building an integrated registry
  • And more

To read the full article, click here.

To learn more about UBC’s observational research experience and capabilities, visit here or get in touch with us.

International Clinical Trials, May 2022, pages 58-60. © Samedan Ltd

Other Recent Posts

Press
4 min read

UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025

UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix®, and a major contender in the Post-approval category. The recognition highlights UBC’s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.
Press
5 min read

UBC Announces Partnership with Osmind to Advance the Future of Mental Health Treatment and Research within REMS

First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes
Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.